The Role of the Central Melanocortin System in the Muscle Wasting of Cachexia
The Role of the Central Melanocortin System in the Muscle Wasting of Cachexia
批准号:
8513316
负责人:
Theodore Paul Braun
金额:
$4.36万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-01 至 2014-05-31
关键词:
AddressAdipose tissueAdrenergic ReceptorAffectAgonistAreaBasal metabolic rateCachexiaCancer ModelCatabolismChronicChronic DiseaseComplicationCytokine SignalingDependenceDesire for foodDiseaseDisease modelDrug DesignEndocrineEquilibriumEtiologyExperimental Animal ModelFOS geneFamilyFutureGene ExpressionGenesGoalsHumanHypothalamic structureInfectionInflammatoryKnockout MiceLabelLeadMalignant NeoplasmsMalnutritionMeasuresMediatingMediator of activation proteinMelanocortin 4 ReceptorMetabolicMetabolismMolecularMorbidity - disease rateMuscleNeural PathwaysNeuronsNeuropeptidesPathogenesisPathway interactionsPatient CarePatientsPatternPhenotypePopulationProcessProteinsProteolysisQuality of lifeRattusRegulationRelative (related person)ResearchResistanceRoleSeveritiesSignal PathwaySignal TransductionSkeletal MuscleStarvationSuid Herpesvirus 1Sympathetic Nervous SystemSystemTherapeutic InterventionTimeTissuesTransgenic MiceWestern BlottingWorkcytokineenergy balanceimprovedincreased appetiteinsightloss of function mutationmelanocortin receptormuscle formnerve supplynew therapeutic targetrelating to nervous systemresearch studytranscription factorubiquitin-protein ligasewasting
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
The goal of this research is to understand the role of the central melanocortin system In the pathogenesis of muscle wasting in cachexia. A patient's ability to maintain lean mass is an important factor in quality of life as well as an important predictor of survival. Currently there are no therapeutic interventions that can improve lean mass retention in chronic disease. The role of the melanocortin system in appetite and basal metabolic rate is well established, but its role in the regulation of the anabolic/catabolic balance of muscle has not been fully examined.
Melanocortin 4 receptor (MC4R) knockout mice have an increased lean mass phenotype, and are resistant to loss of lean mass in cachexia. Pharmacologic blockade of melanocortin receptors also ameliorates experimentally-induced cachexia. Critical to the pathogenesis of muscle breakdown are the muscle specific E3 ubiquitin ligases, MAFbx and MuRF-1.1 have shown that pharmacological activation of the central melanocortin system induces expression of these genes in skeletal muscle. The neuroanatomical pathway by which melanocortin signaling influences muscle is likely to be mediated by the sympathetic nervous system, via the signaling mediators AMPK and the FOXO family of transcription factors. Therefore I will investigate whether the transduction of this signal can be altered by the presence of sympathetic blockade. A signaling pathway by which central melanocortins influence muscle mass will be examined in the setting of pharmacologic melanocortin activation. The signaling pathway established will then be examined in an animal model of experimental cachexia in the presence and absence of melanocortin blockade. By comparing pharmacologic activation to the disease model, a common molecular singnaling pathway in muscle will be identified. Finally, the neuronal connectivity of this pathway will be examined by utilizing a retrograde track tracing approach. Pseudorabies virus will be injected into muscle of MC4R-GFP transgenic mice, and infection of MC4R-positive neurons in the hypothalamus will be examined.
This work will help develop a clearer understanding of the neural component of muscle wasting in cachexia. A mechanistic understanding of this pathway will provide insight into the care of these patients and provide future targets for rational drug design.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
P-selectin genotype is associated with the development of cancer cachexia.
P-选择素基因型与癌症恶病质的发生有关。
DOI:
10.1002/emmm.201200231
发表时间:
2012
期刊:
EMBO molecular medicine
影响因子:
11.1
作者:
[Tan,BenjaminHL, Fladvad,Torill, Braun,TheodoreP, Vigano,Antonio, Strasser,Florian, Deans,DAChristopher, Skipworth,RichardJE, Solheim,ToraS, Damaraju,Sambasivarao, Ross,JamesA, Kaasa,Stein, Marks,DanielL, Baracos,VickieE, Skorpen,F]
通讯作者:
Skorpen,F
DOI:
10.1007/s13539-010-0015-1
发表时间:
2010-12
期刊:
Journal of cachexia, sarcopenia and muscle
影响因子:
--
作者:
[Braun TP, Marks DL]
通讯作者:
Marks DL
Dual Kinase and LSD1 Inhibition in Acute Myeloid Leukemia
-
批准号:10716085
-
项目类别:
-
资助金额:$48.51万
-
财政年份:2023
-
负责人:Theodore Paul Braun
-
依托单位:
Epigenetics of Mutation-Order in Acute Myeloid Leukemia
-
批准号:10596588
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2020
-
负责人:Theodore Paul Braun
-
依托单位:
Epigenetics of Mutation-Order in Acute Myeloid Leukemia
-
批准号:10379071
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2020
-
负责人:Theodore Paul Braun
-
依托单位:
The Role of the Central Melanocortin System in the Muscle Wasting of Cachexia
-
批准号:8113998
-
项目类别:
-
资助金额:$4.45万
-
财政年份:2009
-
负责人:Theodore Paul Braun
-
依托单位:
The Role of the Central Melanocortin System in the Muscle Wasting of Cachexia
-
批准号:8305618
-
项目类别:
-
资助金额:$4.72万
-
财政年份:2009
-
负责人:Theodore Paul Braun
-
依托单位:
The Role of the Central Melanocortin System in the Muscle Wasting of Cachexia
-
批准号:7750694
-
项目类别:
-
资助金额:$4.14万
-
财政年份:2009
-
负责人:Theodore Paul Braun
-
依托单位:
海外基金